Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 3, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 19 March 2026 - 14:44

Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 3, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/hympavzi

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters